AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer.

Radiol Med · 2026 · PMC13369673 · PMID 41915371

Europe PMC DOI

hedged sentence

0.0030

closest p · 0.1× alpha

0.0030

boldest claim

The sentences

highly significantp = 0.003actually significant

Among responders, only 9.09% exhibited sarcopenia, whereas 45.45% of non-responders had sarcopenia, indicating a highly significant association ( p = 0.003).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.